Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reece J Doonan
Observed names:
Doonan, R,
R Doonan,
Reece Doonan
Observed institutions:
Northumbria Healthcare NHS Foundation Trust,
Salford Royal Hospital,
Renewable Energy Alaska Project,
Basildon Hospital,
Canadian Critical Care Trials Group
OpenAlex ID:
A5015221268
Mapping the human genetic architecture of COVID-19
2021
·
COVID-19 Host Genetics Initiative
, COVID-19 Host Genetics InitiativeLeadership
, et al.
·
Nature
·
983
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
2022
·
Gavin D. Perkins
, Chen Ji
, et al.
·
JAMA
·
395
PDF
Whole-genome sequencing reveals host factors underlying critical COVID-19
2022
·
Athanasios Kousathanas
, Erola Pairo-Castineira
, et al.
·
Nature
·
326
PDF
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
224
PDF
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021
·
Hesham Abdelhady
, Marwa Abdelrazik
, et al.
·
JAMA
·
210
PDF
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis
2024
·
Joel M. Dulhunty
, Stephen J. Brett
, et al.
·
JAMA
·
172
PDF
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
146
PDF
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
2022
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
136
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
A second update on mapping the human genetic architecture of COVID-19
2023
·
The COVID-19 Host Genetics Initiative
, Leadership
, et al.
·
Nature
·
118
PDF
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis
2024
·
Paul Dark
, Anower Hossain
, et al.
·
JAMA
·
110
PDF
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
2021
·
Yaseen M. Arabi
, Anthony C. Gordon
, et al.
·
Intensive Care Medicine
·
99
PDF
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
2023
·
Simin Florescu
, Delia Stanciu
, et al.
·
JAMA
·
63
PDF
Intravenous Vitamin C for Patients Hospitalized With COVID-19
2023
·
The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators
, Simin Florescu
, et al.
·
JAMA
·
53
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Global variation in patient factors, interventions, and postoperative outcomes for those undergoing trauma laparotomy: an international, prospective, observational cohort study
2025
·
Michael F Bath
, Michael F Bath
, et al.
·
The Lancet Global Health
·
14
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
2024
·
Jannik Boos
, Caspar I. van der Made
, et al.
·
Human Genetics and Genomics Advances
·
12
PDF
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
9
PDF
Functional vision assessments for visual field loss: a scoping review
2026
·
Reece Doonan
, Lauren Hepworth
, et al.
·
OSF Preprints (OSF Preprints)
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Show more works
View as search
Works count:
24
Citation count:
3,609
H-index:
17
I10-index:
20
Year
Topic
Type